Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

NCT02223481 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Pulmonary

Interventions

DRUG: Terbogrel low dose
DRUG: Terbogrel high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim